Amicus Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$8.29(as of Oct 10, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Amicus Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$8.29
Ticker SymbolFOLD
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees499
CountyUSA
Market Cap$2,345.7M
EBIDTA32.9M
10-Day Moving Average8.11
P/E Ratio-67.10
20-Day Moving Average8.16
Forward P/E Ratio285.71
50-Day Moving Average7.72
Earnings per Share-0.12
200-Day Moving Average7.67
Profit Margin-15.79%
RSI58.01
Shares Outstanding308.2M
ATR0.35
52-Week High12.65
Volume3,643,704
52-Week Low5.51
Most Recent Support Level8.01
Book Value204.3M
Most Recent Resistance Level8.51
P/B Ratio12.51
Upper Keltner8.94
P/S Ratio4.48
Lower Keltner7.39
Debt-to-Equity Ratio8.94
Next Earnings Date11/05/2025
Cash Surplus-8.9M
Next Ex-Dividend DateUnknown

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Amicus Therapeutics Inc In Our Stock Scanner

As of Oct 13, 2025
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.